NEXCELL is a major multi-million-€ collaborative research initiative that brings together leading industrial and academic partners to create a groundbreaking point-of-care platform for next-generation cell and gene therapies. The vision is to enable personalized cancer treatments to be manufactured directly at the clinical site – making life-saving therapies more accessible and scalable. Within this project, the University of Rostock serves as the AI technology provider, developing a probabilistic digital twin of the NEXCELL bioreactor system. This digital twin will combine Bayesian AI, deep learning, symbolic reasoning, and hybrid modeling techniques to intelligently monitor and predict both technical and biological processes. By addressing challenges such as uncertainty quantification, multimodal sensor fusion, anomaly detection, and robust state estimation, our research will push the frontiers of AI in complex, safety-critical, and data-sparse domains. For motivated AI researchers, NEXCELL offers a unique opportunity to conduct fundamental research at the interface of cutting-edge machine learning and real-world bioprocess applications, with the potential for high-impact publications, open-source contributions, and direct collaboration with a market leader in bioreactor technology.
We invite four outstanding early‑career researchers – 2 PhD and 2 Post‑doctoral level – to join our institute in partnership with a global leader in bioreactor technology. In a major research project, you will spearhead the development and application of cutting‑edge AI methods – incl. deep learning, LLMs, probabilistic and symbolic modeling – for transformative system monitoring and state estimation in next‑generation bioreactors. This interdisciplinary role pffers a clear path toward doctoral or postdoctoral qualification, and career development in both academia and industry.
For further information and the application portal, we refer to https://jobs.uni-rostock.de/jobposting/20b177ee5b38c8ec763da3443da877fa657d5b6d0